Vitamin C and Mycobacterium tuberculosis Persisters

@article{Yew2018VitaminCA,
  title={Vitamin C and Mycobacterium tuberculosis Persisters},
  author={W. Yew and K. C. Chang and C. Leung and D. Chan and Y. Zhang},
  journal={Antimicrobial Agents and Chemotherapy},
  year={2018},
  volume={62}
}
We read with great interest the article by Vilchèze and coworkers regarding vitamin C-mediated enhancement of killing of Mycobacterium tuberculosis by first-line antituberculosis drugs in the murine model (1). In this elegant experiment, vitamin C alone was not found to have any antituberculosis activity. However, using high-dose vitamin C, potentiation of bactericidal activity of isoniazid and rifampin in combination was observed. Earlier on, Vilchèze and coworkers suggested the induction of… Expand
4 Citations
Reply to Yew et al., “Vitamin C and Mycobacterium tuberculosis Persisters”
  • PDF
Does oxidative stress contribute to antituberculosis drug resistance?
  • 2

References

SHOWING 1-9 OF 9 REFERENCES
Vitamin C Potentiates the Killing of Mycobacterium tuberculosis by the First-Line Tuberculosis Drugs Isoniazid and Rifampin in Mice
  • 15
  • PDF
Multifaceted remodeling by vitamin C boosts sensitivity of Mycobacterium tuberculosis subpopulations to combination treatment by anti-tubercular drugs
  • 17
Enhanced respiration prevents drug tolerance and drug resistance in Mycobacterium tuberculosis
  • 84
  • PDF
Qualitative and quantitative proteomic analysis of Vitamin C induced changes in Mycobacterium smegmatis
  • 14
Vitamin C targets (p)ppGpp synthesis leading to stalling of long‐term survival and biofilm formation in Mycobacterium smegmatis
  • 20
  • PDF
Oxidative stress and TB outcomes in patients with diabetes mellitus?
  • 14
  • PDF
Does oxidative stress contribute to adverse outcomes in HIV-associated TB?
  • 7
  • PDF